Company Description
Development-stage Alfacell may kiss a few frogs in hopes one will transform into a princely product. The biotechnology firm has isolated proteins...
Key Alfacell Corporation Financials
| Company Type | Public - NASDAQ (CM): ACEL Main Headquarters |
|---|---|
| Fiscal Year-End | July |
| 2006 Sales (mil.) | $0.1 |
| 2006 Employees | 14 |
More Alfacell Corporation Financials (10 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Alfacell Corporation's competition across multiple industries
Top Alfacell Corporation Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Alfacell Corporation Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO | Kuslima (Tina) Shogen | Network | E-mail |
| President, COO, CFO, and Corporate Secretary | Lawrence A. (Larry) Kenyon | Network | E-mail |
| SVP, Commercial Development and Operations | Andrew P. Aromando | Network | E-mail |
More Alfacell Corporation Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Alfacell Corporation News
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (21 Jul 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (21 Jul 2008 22:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 21:00 ET [Briefing.com] (21 Jul 2008 21:00:00 EDT)
Latest Industry Video
-
Rodman & Renshaw Biotech Analyst Michael King (3:30)
10/02/06 10:00AM ET - King discusses Gilead Sciences buing Myogen, Inc. for $2.5 b.